CD28 regulation in liver transplant recipients treated with two different immunosuppressive regimens.
Charco
R
R
Unidad de Transplante Hepático, Barcelona, Spain.
Caragol
I
I
Urbán
S
S
Lázaro
J L
JL
Murio
E
E
Dávila
R
R
Margarit
C
C
D015703:Antigens, CD / Q000276:immunology*; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D018106:CD28 Antigens / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D037181:Lectins, C-Type; D016031:Liver Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*; D000099192:CD69 Antigens
D015703:Antigens, CD; D000945:Antigens, Differentiation, T-Lymphocyte; D018106:CD28 Antigens; D016572:Cyclosporine; D007166:Immunosuppressive Agents; D037181:Lectins, C-Type; D008775:Methylprednisolone; D011241:Prednisone; D016559:Tacrolimus; D000099192:CD69 Antigens